{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:31:44Z","timestamp":1721003504204},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,13]]},"DOI":"10.7759\/cureus.64494","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:58:06Z","timestamp":1720936686000},"source":"Crossref","is-referenced-by-count":0,"title":["Silent Hemoperitoneum Unveils Advanced Cancer"],"prefix":"10.7759","author":[{"given":"Cheng-Chieh","family":"Yen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz278","article-title":"Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis","volume":"35","author":"Elsayed ME","year":"2020","unstructured":"Elsayed ME, Morris AD, Li X, Browne LD, Stack AG. Propensity score matched mortality comparisons of peritoneal and in-centre haemodialysis: systematic review and meta-analysis. Nephrol Dial Transplant. 2020, 35:2172-82. 10.1093\/ndt\/gfz278","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227297","article-title":"A comparison of quality of life between patients treated with different dialysis modalities in Taiwan","volume":"15","author":"Hsu CC","year":"2020","unstructured":"Hsu CC, Huang CC, Chang YC, Chen JS, Tsai WC, Wang KY. A comparison of quality of life between patients treated with different dialysis modalities in Taiwan. PLoS One. 2020, 15:e0227297. 10.1371\/journal.pone.0227297","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2023.03.011","article-title":"Updates on infectious and other complications in peritoneal dialysis: Core Curriculum 2023","volume":"82","author":"Khan SF","year":"2023","unstructured":"Khan SF. Updates on infectious and other complications in peritoneal dialysis: Core Curriculum 2023. Am J Kidney Dis. 2023, 82:481-90. 10.1053\/j.ajkd.2023.03.011","journal-title":"Am J Kidney Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/089686080702700303","article-title":"Hemoperitoneum: bloody peritoneal dialysate in ESRD patients receiving peritoneal dialysis","volume":"27","author":"Lew S","year":"2007","unstructured":"Lew S. Hemoperitoneum: bloody peritoneal dialysate in ESRD patients receiving peritoneal dialysis. Perit Dial Int. 2007, 27:226-33. 10.1177\/089686080702700303","journal-title":"Perit Dial Int"},{"key":"ref5","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel B","year":"2010","unstructured":"Stengel B. Chronic kidney disease and cancer: a troubling connection. J Nephrol. 2010, 23:253-62.","journal-title":"J Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1289","article-title":"Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?","volume":"7","author":"Lee YC","year":"2018","unstructured":"Lee YC, Hung SY, Wang HK, et al.. Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?. Cancer Med. 2018, 7:485-98. 10.1002\/cam4.1289","journal-title":"Cancer Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143617","article-title":"An update on hepatocellular carcinoma in chronic kidney disease","volume":"13","author":"Fabrizi F","year":"2021","unstructured":"Fabrizi F, Cerutti R, Alfieri CM, Ridruejo E. An update on hepatocellular carcinoma in chronic kidney disease. Cancers (Basel). 2021, 13:10.3390\/cancers13143617","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac011","article-title":"The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes","volume":"38","author":"Lees JS","year":"2023","unstructured":"Lees JS, Elyan BM, Herrmann SM, Lang NN, Jones RJ, Mark PB. The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrol Dial Transplant. 2023, 38:1071-9. 10.1093\/ndt\/gfac011","journal-title":"Nephrol Dial Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12563","article-title":"Characteristics and prognosis of hepatocellular carcinoma in Japanese patients undergoing dialysis","volume":"21","author":"Toyoda H","year":"2017","unstructured":"Toyoda H, Hiraoka A, Tada T, et al.. Characteristics and prognosis of hepatocellular carcinoma in Japanese patients undergoing dialysis. Ther Apher Dial. 2017, 21:465-72. 10.1111\/1744-9987.12563","journal-title":"Ther Apher Dial"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271295-silent-hemoperitoneum-unveils-advanced-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:58:10Z","timestamp":1720936690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271295-silent-hemoperitoneum-unveils-advanced-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.64494","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,13]]}}}